Search Results - "Ye, Guolin"

Comprehending the cuproptosis and cancer-immunity cycle network: delving into the immune landscape and its predictive role in breast cancer immunotherapy responses and clinical endpoints by Liu, Xiangwei, Xu, Feng, Zhao, Kunkun, Liu, Yunfei, Ye, Guolin, Zhang, Xin, Qu, Yanyu

“…The role of cuproptosis, a phenomenon associated with tumor metabolism and immunological identification, remains underexplored, particularly in relation to the…”
Get full text

Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer by Yu, Yunfang, Hong, Huangming, Wang, Ying, Fu, Tuping, Chen, Yongjian, Zhao, Jianli, Chen, Peixian, Cai, Ruizhao, Tan, Yujie, He, Zifan, Ren, Wei, Zhou, Lihuan, Huang, Junhao, Tang, Jun, Ye, Guolin, Yao, Herui

“…Background Whether primary tumor surgery is better than no surgery in patients with de novo stage IV breast cancer remains controversial. Methods This study…”
Get full text

Deep learning with biopsy whole slide images for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer：A multicenter study by Li, Bao, Li, Fengling, Liu, Zhenyu, Xu, FangPing, Ye, Guolin, Li, Wei, Zhang, Yimin, Zhu, Teng, Shao, Lizhi, Chen, Chi, Sun, Caixia, Qiu, Bensheng, Bu, Hong, Wang, Kun, Tian, Jie

“…Predicting pathological complete response (pCR) for patients receiving neoadjuvant chemotherapy (NAC) is crucial in establishing individualized treatment…”
Get full text

A comparison of Chinese multicenter breast cancer database and SEER database by Niu, Yingjie, Zhang, Fan, Chen, Dong, Ye, Guolin, Li, Yong, Zha, Yong, Chen, Wenlin, Liu, Dequan, Liao, Xiaoming, Huang, Qinghua, Tang, Wei, Cai, Gengxi, Guo, Rong, Li, Hongyang, Tang, Shicong

“…There are different characteristics of BC in developing countries and developed countries. We intended to study the factors which influence the survival and…”
Get full text

Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy by Lai, Jianguo, Pan, Zihao, Chen, Peixian, Ye, Guolin, Chen, Kai, Su, Fengxi

“…Over the past decade, several studies have highlighted that axillary lymph node ratio (ratio of involved over excised axillary lymph nodes) was a superior…”
Get full text

Tumor-Targeting Extracellular Vesicles Loaded with siS100A4 for Suppressing Postoperative Breast Cancer Metastasis by Pan, Ruiling, He, Tiancheng, Zhang, Kun, Zhu, Lewei, Lin, Jiawei, Chen, Peixian, Liu, Xiangwei, Huang, Huiqi, Zhou, Dan, Li, Wei, Yang, Shuqing, Ye, Guolin

“…Introduction S100A4 promotes the establishment of tumor microenvironment for malignant cancer cells, and knockdown of S100A4 can inhibit tumorigenesis…”
Get full text

The features of male breast cancer in China: A real-world study by Gao, Yuxuan, Zhang, Mengmeng, Sun, Gang, Ma, Li, Nie, Jianyun, Yuan, Zhongyu, Liu, Zhenzhen, Cao, Yali, Li, Jianbin, Liu, Qiang, Ye, Songqing, Chen, Bo, Song, Yuhua, Wang, Kun, Ren, Yu, Ye, Guolin, Xu, Ling, Liu, Shu, Chen, Qianjun, Li, Weiwen, Chen, Xinxin, Fu, Peifen, Wei, Wei, Guo, Baoliang, Wang, Hebing, Cai, Zhenhai, Du, Caiwen, Wu, Zhiyong, Zha, Xiaoming, Huang, Heng, Xu, Juan, Zhang, Chenglei, Shi, Yingying, Liu, Ting, Liu, Sihua, Jiang, Zefei, Lin, Ying

“…Male breast cancer (MBC) is a rare disease. Although several large-scale studies have investigated MBC patients in other countries, the features of MBC…”
Get full text

Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer by Chen, Xiaosong, Ye, Guolin, Zhang, Chenfang, Li, Xinzheng, Chen, Yiding, Xie, Xiaohong, Zheng, Hong, Cao, Yali, Wu, Kejin, Ni, Duo, Tang, Jinhai, Wei, Ziguo, Shen, Kunwei

“…The purpose of this study is to evaluate the efficacy and safety of docetaxel plus cyclophosphamide (TC) compared with docetaxel, anthracycline, and…”
Get full text

Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients by Xiaosong Chen Guolin Ye Chenfang Zhang Xinzheng Li Kunwei Shen

“…Objective： A previous study demonstrated that non-anthracycline-containing docetaxel plus cyclophosphamide（TC） regimen was inferior to docetaxel, anthracycline…”
Get full text

An MRI-based multi-parameter clinical decision support system (NeoMDSS) for early prediction of pathological complete response after the first cycle of neoadjuvant therapy in breast cancer: A multi-center prospective observational cohort study by Zhang, Liulu, Zhu, Zhaowen, Chen, Yuanqi, Wu, Yidan, Zhang, Yongcheng, Ye, Guolin, Li, Wei, Wang, Kun

“…592 Background: Currently, there is no reliable and convenient way to predict response rates in early stages of neoadjuvant therapy (NAT) for breast cancer,…”
Get full text

circ_0041732 Promotes Breast Cancer Progression by Ye, Guolin, He, Suqun, Pan, Ruilin, Zhu, Lewei, Zhou, Dan, Cai, Genxi, Chen, Peixian

“…Abstract Breast cancer is quite a prevalent cancer worldwide, and it is the leading cause of cancer-related deaths among female populations worldwide…”
Get full text

Dynamic changes in intrinsic subtype, immunity status, and risk score before and after neoadjuvant chemo- and HER2-targeted therapy without pCR in HER2-positive breast cancers: A cross-sectional analysis by Chen, Peixian, Mao, Xiaofan, Ma, Na, Wang, Chuan, Yao, Guangyu, Ye, Guolin, Zhou, Dan

“…Very few studies have been done in HER2 positive patients without complete pathological response (pCR) after combined neoadjuvant chemo- and HER2-target…”
Get full text

Treatment and Outcome of 341 Papillary Breast Lesions by Chen, Peixian, Zhou, Dan, Wang, Chuan, Ye, Guolin, Pan, Ruilin, Zhu, Lewei

“…Background Papillary breast lesions constitute a pathological heterogeneous group and display diverse clinical and imaging features. This study was conducted…”
Get full text

Circ_DCAF6 potentiates cell stemness and growth in breast cancer through GLI1-Hedgehog pathway by Ye, Guolin, Pan, Ruilin, Zhu, Leiwei, Zhou, Dan

“…Circular RNAs (circRNAs) are extensively revealed as a malignant activator or suppressor in multiple pathological processes including cancer cell stemness and…”
Get full text

Single-cell and spatial transcriptome analyses revealed cell heterogeneity and immune environment alternations in metastatic axillary lymph nodes in breast cancer by Mao, Xiaofan, Zhou, Dan, Lin, Kairong, Zhang, Beiying, Gao, Juntao, Ling, Fei, Zhu, Lewei, Yu, Sifei, Chen, Peixian, Zhang, Chuling, Zhang, Chunguo, Ye, Guolin, Fong, Simon, Chen, Guoqiang, Luo, Wei

“…Background Tumor heterogeneity plays essential roles in developing cancer therapies, including therapies for breast cancer (BC). In addition, it is also very…”
Get full text

Different maintenance strategies versus observation in patients with hormone receptor-positive metastatic breast cancer after first-line chemotherapy: A real-world study and meta-analysis by Hong, Huangming, Wang, Ying, Yu, Yunfang, Li, Chenchen, Ren, Wei, Tang, Jun, Ye, Guolin, Yao, Herui

“…Abstract only e12529 Background: Current guidelines lack definitive evidence regarding the clinical outcomes associated with different maintenance strategies…”
Get full text

BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer by Zhu, Lewei, Pan, Ruilin, Zhou, Dan, Ye, Guolin, Tan, Weige

“…Breast cancer has become the most common malignant disease threatening women's health. The cancer stem cell (CSC) has been recognized as a small subpopulation…”
Get full text

Multivariable Models Based on Baseline Imaging Features and Clinicopathological Characteristics to Predict Breast Pathologic Response after Neoadjuvant Chemotherapy in Patients with Breast Cancer by Chen, Peixian, Wang, Chuan, Lu, Ruiliang, Pan, Ruilin, Zhu, Lewei, Zhou, Dan, Ye, Guolin

“…Abstract Introduction: Currently, the accurate evaluation and prediction of response to neoadjuvant chemotherapy (NAC) remains a great challenge. We developed…”
Get full text

Non-anthracycline-containing docetaxel and cyclophosphamide regimen is associated with sustained worse outcome compared with docetaxel, anthracycline and cyclophosphamide in neoadjuvant treatment of triple negative and HER2-positive breast cancer patients: updated follow-up data from NATT study by Chen, Xiaosong, Ye, Guolin, Zhang, Chenfang, Li, Xinzheng, Shen, Kunwei

“…A previous study demonstrated that non-anthracycline-containing docetaxel plus cyclophosphamide (TC) regimen was inferior to docetaxel, anthracycline and…”
Get full text

Research on DCE-MRI Images Based on Deep Transfer Learning in Breast Cancer Adjuvant Curative Effect Prediction by Ye, Guolin, He, Suqun, Pan, Ruilin, Zhu, Lewei, Zhou, Dan, Lu, RuiLiang

“…Breast cancer is a serious threat to women's physical and mental health. In recent years, its incidence has been on the rise and it has become the top female…”
Get full text